leisure time -WSS

leisure time

author：explore 2025-10-01 18:35:09 - browse：38899

3d rendered medically accurate illustration of the adrenal gland – biotech and pharma coverage from STAT — Adobe

SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial, bringing the company a step closer to treating patients with a rare and serious set of genetic disorders that alters their ability to produce key hormones.

In the Phase 3 study, known as CAHtalyst, 182 adults were randomly assigned to receive a placebo or crinecerfont, an oral drug Neurocrine developed to lower male sex hormones patients with the disease produce in excess. Researchers found that, compared to those on placebo, participants who took crinecerfont needed a significantly lower dose of the current standard-of-care treatment, glucocorticoids, after 24 weeks of treatment that they did at the study’s start. And about 63% of participants who took crinecerfont were able to lower their dose of glucocorticoids to levels researchers think would be safer for prolonged use, compared to 18% of those on the placebo.

Neurocine, a San Diego biotech focused on treating rare neurological and endocrine diseases, believes the drug could allow people living with congenital adrenal hyperplasia, or CAH, to avoid some of the more serious side effects of glucocorticoids by allowing them to take lower doses. Long-term use of high doses of these drugs can cause patients to gain weight and put them at risk of diabetes, heart disease, and osteoporosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Problems with a popular proposal to regulate AI in health care

WSS

Top private equity targets in 2023: cardiology, clinical trials, lasers

Why does health care cost so much? A reading guide

Cue Health's Covid

Global cancer cases to surge 77% by 2050, WHO report says

340B reform proposal comes out of Senate working group

Bird flu outbreak in cows is latest avian flu curveball

knowledge

leisure time

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

UnitedHealth financials solid despite Change Healthcare cyberattack

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What’s missing from the debate over nursing home staff minimums

Walensky prepares to leave CDC — and Congress — behind

Gene therapy for Afghan refugees’ infant will be fully covered

Anesthesiologist group: stop taking Ozempic before surgery

Texas Medical Board asked to define abortion emergency exception

In age of alternative facts, a scholarly course on calling out crap

Element Biosciences CEO lays out genome sequencing strategy

knowledge

Close Medicare's dangerous gaps in addiction treatment coverage

Cancer researcher Catriona Jamieson is sending tumors into space

Why does health care cost so much? A reading guide

Global cancer cases to surge 77% by 2050, WHO report says

Bird flu in milk supply is likely coming from asymptomatic cows

Melinda French Gates resigns from Gates Foundation

focus

leisure time

explore

Wikipedia